Jacqualyn Fouse

Track

Insider profile

Currently holds positions in Agios Pharmaceuticals, Inc., Dick's Sporting Goods Inc and Incyte Corp

Positions

Position Company Period
Chief Executive Officer, Director Agios Pharmaceuticals, Inc. Feb. 1, 2019 -
Independent Director Dick's Sporting Goods Inc Sept. 15, 2010 -
Independent Director Incyte Corp Nov. 14, 2017 -
Director Agios Pharmaceuticals, Inc. Dec. 5, 2017 - Feb. 1, 2019
Director Celgene Corp April 1, 2017 - June 30, 2017
President, Chief Operating Officer, Director Celgene Corp March 1, 2016 - April 1, 2017
President - Hematology & Oncology, Director Celgene Corp Feb. 12, 2016 - March 1, 2016
President - Hematology & Oncology Celgene Corp May 22, 2014 - Feb. 11, 2016
Independent Director Perrigo Company PLC Nov. 6, 2012 - Jan. 1, 2016
Chief Financial Officer, Executive Vice President Celgene Corp Feb. 15, 2012 - May 22, 2014
Chief Financial Officer, Senior Vice President, Chief Accounting Officer Celgene Corp Nov. 15, 2011 - Feb. 15, 2012
Jacqualyn Fouse's trades of Agios Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
191.09
Quantity 77,835
Value US$1,439,847
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-10 2025-04-10
PlS Planned sale
92,408 +22.9%
158.41
US$3,572,113 		92,408 +22.9% 158.41 US$3,572,113
2025-04-08 2025-04-08
PrS Proposed sale
77,835
191.09
US$1,439,847 		77,835 191.09 US$1,439,847
2024-04-10 2024-04-10
PlS Planned sale
75,326 -35.7%
210.10
US$2,209,119 		75,326 -35.7% 210.10 US$2,209,119
2024-01-24 2024-01-24
PlS Planned sale
10,722 -7.7%
21.64
US$232,024 		10,722 -7.7% 21.64 US$232,024
2024-01-09 2024-01-09
PlS Planned sale
8,391 -6.7%
22.99
US$192,909 		8,391 -6.7% 22.99 US$192,909
2019-11-15 2019-11-13
B Purchase
40,322 +2880.1%
31.00
US$1,249,982 		40,322 +2880.1% 31.00 US$1,249,982